Corcept therapeutics Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Corcept therapeutics Contact Number

Contact Us Corcept Therapeutics

1 hours ago Corcept.com Show details

650-327-3270

149 Commonwealth Drive Menlo Park, CA 94025. Phone: 650-327-3270 Fax: 650-327-3218 Email: [email protected]corcept.com

1. 149 Commonwealth Dr, Menlo Park, CA 94025 · (650) 327-3270DIRECTIONSWEBSITE

Category: Contact SupportShow more

Corcept Therapeutics Incorporated Company Profile Menlo

7 hours ago Dnb.com Show details

(650) 327-3270

Find company research, competitor information, contact details & financial data for Corcept Therapeutics Incorporated of Menlo Park, CA. Get the latest business insights from Dun & Bradstreet.

Employees: 136
Phone: (650) 327-3270
Location: 149 Commonwealth Dr, Menlo Park, 94025-1133, CA

Category: Contact NumberShow more

Corcept Therapeutics Crunchbase Company Profile & Funding

Just Now Crunchbase.com Show details

Company Type For Profit. Contact Email [email protected]corcept.com. Phone Number 16503273218. Since our founding in May 1998 we have been focused on the impact of cortisol and the potential benefits of developing glucocorticoid receptor antagonists. About 80 percent of the tissues in the body have receptors for cortisol, and the effects of excess cortisol

Founded: 1998

Category: Contact NumberShow more

Corcept Therapeutics Glucocorticoid Receptor Antagonist

4 hours ago Corcept.com Show details

Corcept is a leader in the research and development of cortisol modulators. Learn more about our work, products, and commitment to patients.

Category: Contact NumberShow more

Contact Us Korlym® (mifepristone)

4 hours ago Korlym.com Show details

You can also call the SPARK contact center with any questions that you may have at 1-855-4Korlym, Monday through Friday, 8 AM to 7 PM Eastern time. MedWatch: The FDA Safety Information and Adverse Event Reporting Program. Side effects may be reported to the FDA at: 1-800-FDA-1088. For more information

Category: Contact SupportShow more

Amy FieldSmith Email, Phone Patient Advocate Manager

4 hours ago Adapt.io Show details

Find Amy Field-Smith's accurate email address and contact/phone number in Adapt.io. Currently working as Patient Advocate Manager at Corcept Therapeutics in California, United States.

Category: Phone NumberShow more

Corcept Therapeutics Company Profile Office Locations

7 hours ago Craft.co Show details

Corcept Therapeutics has 206 employees at their 1 location and $353.87 M in annual revenue in FY 2020. See insights on Corcept Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Category: Contact NumberShow more

Corcept Therapeutics Email Format corcept.com Emails

3 hours ago Rocketreach.co Show details

Corcept Therapeutics Email Format. Corcept Therapeutics uses 1 email formats, with first_initial last (ex. [email protected]corcept.com) being used 100.0% of the time. Get Verified Emails for Corcept Therapeutics Employees. Corcept Therapeutics's Email Format.

Category: Contact NumberShow more

Patient Advocate Support Program Korlym® (mifepristone)

Just Now Korlym.com Show details

855-295-9969

If you would like to speak with your Korlym Patient Advocate, call 1-855-295-9969 or email: patientadvocate@corcept.com Important Safety Information and Indications IMPORTANT SAFETY INFORMATION ABOUT KORLYM, INCLUDING IMPORTANT WARNING ON LOSS OF PREGNANCY.

Category: Support NumberShow more

Corcept Therapeutics Incorporated (CORT) Company Profile

6 hours ago Stockanalysis.com Show details

Company profile for Corcept Therapeutics Incorporated (CORT) with a description, list of executives, contact details and other key facts. Company profile for Corcept Therapeutics Incorporated (CORT) with a description, list of executives, contact details and other key facts. CUSIP Number: 218352102: ISIN Number: US2183521028: Employer ID

Category: Contact NumberShow more

Corcept Therapeutics Employees, Board Members, Advisors

7 hours ago Crunchbase.com Show details

Corcept Therapeutics has 6 board members and advisors, including Patrick Enright. Patrick Enright Board Member 2008. David Mahoney Board Member 2005. Dan Bradbury Board Member.

Category: Contact NumberShow more

Investigation of Corcept Therapeutics Incorporated

9 hours ago Robbinsllp.com Show details

In 2012, Corcept Therapeutics Incorporated (CORT) launched its prescription medicine Korlym, which served as Corcept’s only revenue-generating product. Due to the limited number of potential Korlym users, Corcept’s officers and directors improperly paid doctors to prescribe Korlym for non-approved applications and disguised these bribes as

Category: Contact NumberShow more

SEC Filing Corcept

8 hours ago Ir.corcept.com Show details

Item 8.01. Other Events. On June 15, 2021, Corcept Therapeutics Incorporated (“Corcept”) issued a press release announcing that it has entered into an agreement with Sun Pharmaceutical Industries Limited and related entities (“Sun”) resolving patent litigation related to Korlym®, Corcept’s medication for the treatment of patients

Category: Contact NumberShow more

Corcept Therapeutics Profile GetCompanyInfo

Just Now Getcompanyinfo.com Show details

Corcept Therapeutics Website Traffic Analysis In October, 2019 corcept.com's total website visitor was 1755, declined by 84% from previous month. Some key metrics are Average time spent on site is 2 minutes, Bounce Rate is 0% and average page per visit is 4 respectively.

Category: Contact NumberShow more

CORCEPT Trademark of Corcept Therapeutics Incorporated

2 hours ago Trademarkelite.com Show details

The CORCEPT trademark was assigned an Application Number # 015026438 – by the European Union Intellectual Property Office (EUIPO). Trademark Application Number is a unique ID to identify the CORCEPT mark in EUIPO. The CORCEPT mark is filed in the category of Pharmaceutical Products.

Category: Contact NumberShow more

Company Corcept Therapeutics News, Employees and Funding

5 hours ago Topionetworks.com Show details

Leading the discovery and development of drugs that regulate the effects of cortisol Since our founding in May 1998 we have been focused on the impact of cortisol and the potential benefits of developing glucocorticoid receptor antagonists. About 80 percent of the tissues in the body have receptors for cortisol, and the effects of excess cortisol are severe and often life-threatening.

Category: Contact NumberShow more

CORCEPT THERAPEUTICS UK LIMITED Overview (free company

5 hours ago Find-and-update.company-information.service.gov.uk Show details

People. for CORCEPT THERAPEUTICS UK LIMITED (10694542) More. for CORCEPT THERAPEUTICS UK LIMITED (10694542) Registered office address. C/O Legalinx Limited Tallis House, 2 Tallis Street, Temple, London, United Kingdom, EC4Y 0AB. Company status.

Category: Contact NumberShow more

Corcept Announces Presentation of Positive Results From

6 hours ago Ir.corcept.com Show details

Data from Corcept’s 178-patient, randomized, controlled, Phase 2 trial to be featured in a proffered paper oral presentation at the upcoming ESMO conference on September 17, 2021; Results show benefit experienced by women with recurrent platinum-resistant ovarian cancer who were treated with nab-paclitaxel plus Corcept’s proprietary selective cortisol modulator, relacorilant

Category: Contact NumberShow more

Corcept Therapeutics Number of Employees 20062021 CORT

7 hours ago Macrotrends.net Show details

Corcept Therapeutics number of employees from 2006 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis

Category: Contact NumberShow more

CORT Graham Number Corcept Therapeutics GuruFocus.com

6 hours ago Gurufocus.com Show details

021-10-05

As of today (2021-10-05), the stock price of Corcept Therapeutics is $19.78. Corcept Therapeutics's graham number for the quarter that ended in Jun. 2021 was $8.78. Therefore, Corcept Therapeutics's Price to Graham Number ratio for today is 2.25. The historical rank and industry rank for Corcept Therapeutics's Graham Number or its related term

Rating: 1/5

Category: Contact NumberShow more

Radhika Sharma Clinical Trial Manager at Corcept

8 hours ago Apollo.io Show details

View Radhika Sharma's business profile as Clinical Trial Manager at Corcept Therapeutics at Corcept Therapeutics. Find Radhika's email address, mobile number, work history, and more.

Category: Contact NumberShow more

Contact – Encoded Therapeutics

8 hours ago Encoded.com Show details

650.491.0272

Contact. Address 341 Oyster Point Blvd. South San Francisco, CA 94080. Phone 650.491.0272. Social Media

Category: Contact SupportShow more

Corcept Announces Presentation of Positive Results From

2 hours ago Globenewswire.com Show details

Presentation Number: 721O. About Corcept Therapeutics. Corcept is a commercial-stage company engaged in the discovery and development of drugs to …

1. Author: Corcept Therapeutics Incorporated

Category: Contact NumberShow more

Corcept Therapeutics: The Company That Perfectly Explains

4 hours ago Ffj-online.org Show details

The other day, the Southern Investigative Reporting Foundation (SIRF) published a report on Corcept Therapeutics (CORT). Corcept Therapeutics is a small pharmaceutical company that markets Korlym (mifepristone) in a rare disease called Cushing’s Syndrome, a condition that results from excessive exposure to the cortisol.

Category: Contact NumberShow more

Single Dose Absorption, Distribution, Metabolism, and

7 hours ago Clinicaltrials.gov Show details

176-651 2021

Corcept Therapeutics: ClinicalTrials.gov Identifier: NCT04990310 Other Study ID Numbers: CORT113176-651 2021-002544-78 ( EudraCT Number ) First Posted: August 4, 2021 Key Record Dates: Last Update Posted: August 4, 2021 Last Verified: June 2021 Individual Participant Data (IPD) Sharing Statement:

Category: Contact NumberShow more

$CORT: Investors will love the forecast for Corcept

5 hours ago Wallstreetfacts.com Show details

The 52-week high for Corcept Therapeutics Incorporated is $31.18 and the low is $16.52. We will be moving onto the number of outstanding shares. One is that you can use shares outstanding to calculate the market capitalization, the total value, of a corporation.

Category: Contact NumberShow more

Corcept Therapeutics Incorporated – Schall Law Firm

3 hours ago Schallfirm.com Show details

Corcept Therapeutics Incorporated. Join Class Action » According to the Complaint, the Company made false and misleading statements to the market. Corcept made improper payments to doctors to promote its drug, Korlym. The Company also heavily promoted the drug for off-label uses. Corcept’s single specialty pharmacy was a related party.

Category: Contact NumberShow more

Corcept Therapeutics Incorporated. TheStreet

6 hours ago Thestreet.com Show details

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and

Category: Contact NumberShow more

Corcept Therapeutics (CORT)

4 hours ago Forbes.com Show details

Abbott’s current market cap-to-operating income ratio of 41x compares with 12x for Emergent Biosolutions, 19x for Vertex Pharmaceuticals, and 22x for Corcept Therapeutics. Does this gap in

Category: Contact NumberShow more

CORT Corcept Therapeutics Inc. Stock Price & News WSJ

3 hours ago Wsj.com Show details

News Corcept Therapeutics Inc.CORT. No news for in the past two years. Key Stock Data. P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the

Category: Contact NumberShow more

Corcept Therapeutics to Announce Preliminary Selected

3 hours ago Globenewswire.com Show details

The conference ID number is 9289307. About Corcept Therapeutics Incorporated . CONTACT: Christopher S. James, MD Director, Investor Relations

Category: Contact NumberShow more

CORCEPT THERAPEUTICS INCORPORATED : Shareholders Board

6 hours ago Marketscreener.com Show details

Corcept Therapeutics Incorporated is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders.

Category: Contact NumberShow more

Corcept Announces Presentation of Positive Results From

1 hours ago Stocktitan.net Show details

Presentation Number: 721O. Session: Gynecological Cancers Proffered Paper Session. About Corcept Therapeutics. Corcept is a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of the hormone cortisol. CONTACT: Corcept

Category: Contact NumberShow more

Corcept Therapeutics EquityNet

8 hours ago Equitynet.com Show details

Corcept Therapeutics. Menlo Park, CA 94026, US. Biotechnology. www.corcept.com. Corcept Therapeutics discovers and develops drugs that regulate the effects of cortisol. Since our founding in May 1998 we have been focused on the impact of cortisol and the potential benefits of developing glucocorticoid receptor antagonists. About 80 percent of

Category: Contact NumberShow more

CORT News Today (Corcept Therapeutics) MarketBeat

1 hours ago Marketbeat.com Show details

Corcept Therapeutics Incorporated (CORT) Q2 2021 Earnings Call Transcript fool.com - July 30 at 5:01 AM: Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update finance.yahoo.com - July 29 at 8:14 PM: Corcept Therapeutics (CORT) Q2 Earnings and Revenues Surpass Estimates finance.yahoo.com - July 29 at 8:14 PM

Category: Contact NumberShow more

Corcept Therapeutics Announces Second Quarter Financial

1 hours ago Finance.yahoo.com Show details

MENLO PARK, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe

1. Author: Corcept Therapeutics Incorporated

Category: Contact NumberShow more

Investigation of Corcept Therapeutics Robbins LLP

5 hours ago Robbinsllp.com Show details

Corcept Therapeutics Incorporated (CORT) Accused of Illicit Sales Practices. According to allegations for breaches of fiduciary duty, mismanagement, corporate waste, and violations of the Securities Exchange Act of 1934, in 2012, Corcept Therapeutics Incorporated (CORT) launched its prescription medicine Korlym, which served as Corcept’s only

Category: Contact NumberShow more

Corcept Announces Presentation of Positive Results From

2 hours ago Apnews.com Show details

Corcept Therapeutics Incorporated September 9, 2021 GMT Data from Corcept’s 178-patient, randomized, controlled, Phase 2 trial to be featured in a proffered paper oral presentation at the upcoming ESMO conference on September 17, 2021

Category: Contact NumberShow more

CORT Corcept Therapeutics Incorporated Stock Quote

6 hours ago Finviz.com Show details

13-20 05

Nov-13-20 05:36AM. George Baker Is The Independent Director of Corcept Therapeutics Incorporated (NASDAQ:CORT) And Just Spent US$243k On Shares. Simply Wall St. Nov-05-20 10:53AM. New Strong Sell Stocks for November 5th. Zacks. Nov-04-20 12:08PM. Corcept (CORT) Misses on Q3 Earnings, Tightens 2020 Sales View. Zacks.

Category: Contact NumberShow more

What Are Analyst Opinions Regarding Corcept Therapeutics

3 hours ago Baxterreport.com Show details

Corcept Therapeutics Incorporated (CORT) saw an uptrend of 1.43% in the recent trading with $19.84 being its most recent. The current price level -36.37% lower than the highest price of $31.18 marked by the stock while trading over the past 52-weeks, whereas it is 20.10% higher than the lowest price of $16.52 the company dropped to over past 52-weeks.

Category: Contact NumberShow more

Insider Selling: Corcept Therapeutics Incorporated (NASDAQ

9 hours ago Marketbeat.com Show details

Corcept Therapeutics Incorporated (NASDAQ:CORT) insider Sean Maduck sold 24,363 shares of the firm's stock in a transaction on Friday, October 1st. The stock was sold at an average price of $20.00, for a total value of $487,260.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Category: Contact NumberShow more

Insider Trading Transactions at Corcept Therapeutics Inc

3 hours ago Form4oracle.com Show details

Corcept Therapeutics Inc. (CORT) 01-Oct-21: Option Exercise : 24,363: $3.29: $80,154.30: 41% 60.02K to 84.39K: 05-Oct-21 6:17 PM View: Maduck Sean Chief Commercial Officer: Corcept Therapeutics Inc. (CORT) 01-Oct-21: Market Option Sale (Planned) 24,363: $20.00: $487,374.00 (29%) 84.39K to 60.02K: 15-Sep-21 6:13 PM View: Robb Gary Charles Chief

Category: Contact NumberShow more

Corcept Therapeutics Inc Sample Contracts Law Insider

7 hours ago Lawinsider.com Show details

Corcept Therapeutics Inc – Corcept Therapeutics Incorporated 10,000,000 Shares Common Stock ($0.001 par value) Underwriting Agreement. Corcept Therapeutics Incorporated, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters named in Schedule I hereto (collectively, the “Underwriters”), for

Category: Contact NumberShow more

Corcept Therapeutics: Jobs LinkedIn

8 hours ago Linkedin.com Show details

Corcept Therapeutics 9,158 followers on LinkedIn. Where patients come first. Leading the field in the discovery of drugs that modulate the effects of cortisol. The adverse effects of excess

Category: Contact NumberShow more

Buy shares of Corcept Therapeutics Inc stock (CORT) Stash

1 hours ago Stash.com Show details

Stash allows you to purchase smaller pieces of investments, called fractional shares, rather than having to pay the full price for a whole share. , you can buy Corcept Therapeutics Inc stock in any dollar amount, or any other fund or stock you know on Stash. $5. $25. $50.

Category: Contact NumberShow more

Corcept Announces Presentation of Positive Results From

Just Now Marketscreener.com Show details

MENLO PARK, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol, today announced that results from its 178-patient, randomized

Category: Contact NumberShow more

How A Drugmaker Turned The Abortion Pill Into A Rare

7 hours ago Khn.org Show details

Corcept Therapeutics, a Silicon Valley-based drug company, began marketing Korlym six years ago as a specialty drug for about 10,000 rare-disease patients such as Edwin. The difference in …

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

Where is corcept therapeutics in menlo park ca?

And a case in point would be Corcept Therapeutics, a specialty pharmaceutical company based in Menlo Park, California, and the apparent union of all things expensive and opaque. So how did Corcept, a small company with just one drug aimed at treating a tiny population of patients with a rare pituitary disorder, wind up there?

When was cort corcept therapeutics incorporated founded?

Corcept Therapeutics Incorporated was founded in 1998 and is headquartered in Menlo Park, California. Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, historical statements, and much more.

What kind of diseases does corcept therapeutics treat?

Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders in the United States.

Who is the cfo of corcept therapeutics?

In a late December 2018 interview, Corcept’s CFO Charles Robb told the Southern Investigative Reporting Foundation that the reason the company pulled Corluxin’s application was “primarily commercial.”

Brand New Updated

Popular Brands

Costco
Cisco
Ccu
Cae